Biophysics in the Understanding, Diagnosis, and Treatment of Infectious Diseases Poster Abstracts
74
34-POS
Board 34
DNA Methylation Analysis to Reveal Latent HIV Reactivation Mechanism in Single Cell
Yutaka Negishi
1
, Musa Mhlanga
2
.
1
RIKEN, Yokohama, Japan,
2
Council for Scientific and Industrial Research, Pretoria, South
Africa.
Despite the suite of effective anti-HIV drugs available, curation of HIV infection is still difficult
due to the presence of latent provirus in resting memory T cells. This latent reservoir is
established early stage during HIV infection and remains a major barrier to curing HIV infection
because latent HIV is unaffected to anti-HIV drugs. One approach to make anti-HIV drugs more
effective is reactivating latent HIV artificially. Although some reagents can reactivate latent
HIV, it is difficult to reactivate all latent HIV. Therefore, understanding reactivation mechanism
of latent HIV in single cell level is important to cure the HIV.
Here, we propose to develop a novel technique able to reveal the methylation status of latent
HIV in single cell level based on the adaptation of the padlock FISH approach. DNA methylation
in the HIV provirus 5′ or 3’ long terminal repeat (LTR) is considered to be a mechanism of
transcriptional suppression that allows retroviruses to evade host immune responses and anti-
HIV drugs. In our technique, DNA is digested with a DNA methylation sensitive restriction
enzyme such as HpaII, and subsequently generated single strand by lambda 5’-3’exonuclease.
The padlock probes, which contain the sequence of HIV 5’ and 3’ LTR near the restriction site
and detection sequence, are annealed to the target DNA and the ends of the probes are
circularized by ligation. Then, phi29 DNA polymerase amplifies circularized DNA by rolling-
circle amplification and amplified DNA product is detected by hybridization of fluorescent-
labelled oligonucleotides. In this way, we will be able to specifically visualize integrated
provirus that is methylated and reveal methylation status in 5’ and 3’ LTR. Our technique will
provide a novel approach to develop novel drugs to reactivate latent HIV.